U.S. equity markets presented a mixed picture in midday trading on Tuesday, with the Dow Jones Industrial Average and the S&P 500 holding onto slight gains while the Nasdaq Composite edged lower. The divergence comes as a rebound in artificial-intelligence-related stocks encountered headwinds ahead of a critical inflation report due later this week.
According to delayed data from LSEG, the S&P 500 rose 0.22% to 7,421.81, while the Dow added 0.30% to reach 50,940.88. In contrast, the Nasdaq slipped 0.03% to 25,921.29, reflecting ongoing uncertainty in the technology sector following last week's sharp sell-off.
Inflation Data in Focus
Investor attention is squarely on the Labor Department's upcoming release of May's Consumer Price Index (CPI), scheduled for 8:30 a.m. EDT Wednesday. The data is expected to provide crucial clues about the trajectory of inflation and its potential impact on Federal Reserve policy. A hotter-than-expected reading could reignite fears of prolonged tighter monetary conditions, posing a risk to equity valuations, particularly in high-growth tech stocks.
Ken Mahoney, CEO of Mahoney Asset Management, noted that the market is holding up reasonably well, supported by analysts who continue to raise their earnings guidance. However, the sustainability of this resilience remains a key question.
AI and Tech Stocks in the Spotlight
The technology sector remained a focal point, with several semiconductor stocks gaining ground. Intel, Broadcom, and Micron all posted gains ranging from 1.5% to 3.2%, lifting the Philadelphia Semiconductor Index by 2.3%. This bounce suggests some investor appetite for beaten-down AI-related names, though caution persists.
In a notable development, Applied Digital, an AI infrastructure company, announced a 15-year lease agreement worth $5.2 billion with a U.S. hyperscaler for computing capacity at its Delta Forge 2 facility. The deal, covering 210 megawatts, could potentially expand to $12.7 billion over 30 years if renewal options are exercised, according to the company.
M&A Activity Boosts Sentiment
Merger and acquisition news provided a bright spot for the market. Shares of Nuvalent surged after GSK agreed to acquire the cancer drug developer in an all-cash deal valued at $10.6 billion. The offer price of $124 per share represents a 40% premium over the stock's Monday close. GSK's chief commercial officer, Luke Miels, described the acquisition as essentially "three products in one," highlighting the strategic value of Nuvalent's pipeline. James Eugene of Verso Investment Management remarked that the size of the deal may have caught some investors off guard. Established lung cancer treatments from Pfizer and Roche remain significant competitors in the space.
Oil Prices Slide, Supporting Equities
A decline in oil prices offered some relief to the broader market. Brent crude fell 3.3% to settle at $91.14 per barrel, according to the Associated Press. The drop in energy costs provided a tailwind for airline stocks, with United Airlines climbing 3% and Delta Air Lines rising 2.8%. Lower fuel expenses are generally viewed as a positive for transportation and consumer sectors.
The 10-year Treasury yield edged down to 4.54% from 4.56% late Monday, reflecting a modest easing in bond market pressure.
Rate Expectations Remain Elevated
Despite the dip in yields, market participants remain cautious about the interest rate outlook. The CME Group's FedWatch tool, which tracks rate expectations based on 30-day fed funds futures, indicates that traders are pricing in the possibility that the Fed may need to maintain a tighter policy stance if inflation does not moderate sufficiently. This uncertainty continues to weigh on sentiment.
Analyst Warnings and Cautious Outlook
Some analysts have expressed concerns that the recent rebound in tech stocks may be more of a short-term oversold bounce rather than the start of a sustained uptrend. Bank of America's Savita Subramanian advised clients in a note late Friday to "take profits," citing stretched market conditions and multiple red flags. Meanwhile, Morgan Stanley's Mike Wilson struck a less alarmist tone, suggesting that a correction was inevitable and ultimately healthy for the market.
For now, buying interest has emerged when oil eases and chip stocks stabilize, but this support could quickly evaporate. A stronger-than-expected CPI print on Wednesday, a renewed rally in crude oil, or further selling in expensive AI shares could undermine the Dow's modest gains and threaten the S&P 500's early advance. The market remains at a critical juncture, with the inflation data likely to set the tone for the near term.
